Related Experiment Video
Updated: Dec 9, 2025
Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility
Published on: April 13, 2017
Microglia as therapeutic target in central nervous system disorders
Oluwaseun Fatoba1, Takahide Itokazu2, Toshihide Yamashita3
1Department of Molecular Neuroscience, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan; WPI-Immunology Frontier Research Center, Osaka University, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan.
Abstract:
Chronic microglial activation is associated with the pathogenesis of several CNS disorders. Microglia show phenotypic diversity and functional complexity in diseased CNS. Thus, understanding the pathology-specific heterogeneity of microglial behavior is crucial for the future development of microglia-modulating therapy for variety of CNS disorders. This review summarizes up-to-date knowledge on how microglia contribute to CNS homeostasis during development and throughout adulthood. We discuss the heterogeneity of microglial phenotypes in the context of CNS disorders with an emphasis on neurodegenerative diseases, demyelinating diseases, CNS trauma, and epilepsy. We conclude this review with a discussion about the disease-specific heterogeneity of microglial function and how it could be exploited for therapeutic intervention.
Insights
Microglia, the immune cells of the central nervous system (CNS), exhibit diverse behaviors in various CNS disorders. Understanding this heterogeneity is key to developing targeted microglia-modulating therapies for neurological conditions.
Area of Science:
- Neuroimmunology
- Cellular Biology
- Neuroscience
Background:
- Chronic microglial activation is implicated in the pathogenesis of numerous central nervous system (CNS) disorders.
- Microglia display significant phenotypic diversity and functional complexity within the diseased CNS environment.
Purpose of the Study:
- To review current knowledge on microglial roles in CNS homeostasis from development through adulthood.
- To discuss the heterogeneity of microglial phenotypes across various CNS disorders, including neurodegenerative diseases, demyelinating diseases, CNS trauma, and epilepsy.
- To explore the potential of exploiting disease-specific microglial functional heterogeneity for therapeutic interventions.
Main Methods:
- Literature review of up-to-date research on microglial function and heterogeneity in CNS disorders.
- Synthesis of information regarding microglial contributions to CNS homeostasis and pathology.
- Analysis of phenotypic and functional diversity of microglia in specific disease contexts.
Main Results:
- Microglia play critical roles in maintaining CNS homeostasis during development and adulthood.
- Significant heterogeneity exists in microglial phenotypes and functions depending on the specific CNS pathology.
- This heterogeneity is evident in neurodegenerative diseases, demyelinating diseases, CNS trauma, and epilepsy.
Conclusions:
- Understanding the diverse roles and phenotypes of microglia in different CNS disorders is essential.
- The pathology-specific heterogeneity of microglial function presents a promising avenue for developing novel therapeutic strategies.
- Targeting specific microglial functions could lead to more effective treatments for a range of CNS disorders.
